Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-036377
Filing Date
2022-10-06
Accepted
2022-10-06 12:21:24
Documents
6
Period of Report
2022-12-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20005256x1_pre14a.htm PRE 14A 814157
2 logo_galectin.jpg GRAPHIC 26119
3 ny20005256x1_pc01.jpg GRAPHIC 749074
4 ny20005256x1_pc02.jpg GRAPHIC 579184
5 sig_jlewis.jpg GRAPHIC 12813
6 sig_jwcallicutt.jpg GRAPHIC 17818
  Complete submission text file 0001140361-22-036377.txt   2721551
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31791 | Film No.: 221297577
SIC: 2834 Pharmaceutical Preparations